SCHEMBL6053403

SCHEMBL6053403

Cc1cc(C)c(O)c(CN(C)CCN(C)Cc2cc(C)cc(C)c2O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.41
ERBB2 P04626 3/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
GLA P06280 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
CYP2C9 P11712 4/20 0.38
CYP2C19 P33261 4/20 0.38
HIF1A Q16665 3/20 0.38
CYP2D6 P10635 2/20 0.38
CYP1A2 P05177 1/20 0.38
PYCR1 P32322 1/20 0.38
SHBG P04278 1/20 0.36
ALOX15 P16050 2/20 0.35
HSD17B10 Q99714 2/20 0.35
AMY1A P0DUB6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13318451 0.87 EGFR (0.40) EGFRERBB2ALDH1A1KDM4EGAA
SCHEMBL6053448 0.87 PRMT1 (0.41) EGFRERBB2ALDH1A1KDM4EGAA
SCHEMBL10936707 0.84 GLA (0.53) EGFRERBB2ALDH1A1KDM4EGAA
SCHEMBL30487695 0.82 KDM4E (0.42) EGFRERBB2ALDH1A1KDM4EGAA
SCHEMBL29757308 0.82 KDM4E (0.45) EGFRERBB2ALDH1A1KDM4EGAA
SCHEMBL3641661 0.82 KDM4E (0.45) EGFRERBB2ALDH1A1KDM4EGAA
SCHEMBL360477 0.81 CYP2C19 (0.54) EGFRALDH1A1KDM4EGLATSHR
SCHEMBL359097 0.81 HIF1A (0.41) EGFRERBB2ALDH1A1KDM4EGAA
SCHEMBL18359692 0.81 ALDH1A1 (0.48) EGFRERBB2ALDH1A1KDM4EGAA
SCHEMBL15221008 0.80 GLA (0.40) EGFRERBB2ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370591-B1 ACTIVE NON-METALLOCENE PRE-CATALYST AND METHOD FOR TACTIC CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS UNIV RAMOT (IL) 2006-08-02 EP claimed
EP-1370591-A4 ACTIVE NON-METALLOCENE PRE-CATALYST AND METHOD FOR TACTIC CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS UNIV RAMOT (IL) 2004-04-21 EP claimed
US-6686490-B1 NON-METALLOCENE PRE- CATALYST FEATURING A DIAMINE DIPHENOLATE COMPLEX RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) 2004-02-03 US claimed
EP-1370591-A2 ACTIVE NON-METALLOCENE PRE-CATALYST AND METHOD FOR TACTIC CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS Ramot at Tel Aviv University Ltd. (IL) 2003-12-17 EP claimed
US-6632899-B2 Contains a diamine diphenolate complex and an activating co-catalyst RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2003-10-14 US claimed
US-20020173604-A1 Active non-metallocene pre-catalyst and method for tactic catalytic polymerization of alpha-olefin monomers RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2002-11-21 US claimed
WO-2002036638-A2 ACTIVE NON-METALLOCENE PRE-CATALYST AND METHOD FOR TACTIC CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) 2002-05-10 WO claimed
US-20220118379-A1 Separation of Radiometals TECHNICAL UNIVERSITY OF DENMARK (DK) 2022-04-21 US disclosed
WO-2020030659-A1 SEPARATION OF RADIOMETALS TECHNICAL UNIVERSITY OF DENMARK (DK) 2020-02-13 WO disclosed
US-20150087795-A1 LIGANDS DESIGNED TO PROVIDE HIGHLY ACTIVE CATALYST COMPLEXES CARNEGIE MELLON UNIVERSITY 2015-03-26 US disclosed
EP-1370591-B1 ACTIVE NON-METALLOCENE PRE-CATALYST AND METHOD FOR TACTIC CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS UNIV RAMOT (IL) 2006-08-02 EP disclosed
EP-1370591-A4 ACTIVE NON-METALLOCENE PRE-CATALYST AND METHOD FOR TACTIC CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS UNIV RAMOT (IL) 2004-04-21 EP disclosed
US-6686490-B1 NON-METALLOCENE PRE- CATALYST FEATURING A DIAMINE DIPHENOLATE COMPLEX RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) 2004-02-03 US disclosed
EP-1370591-A2 ACTIVE NON-METALLOCENE PRE-CATALYST AND METHOD FOR TACTIC CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS Ramot at Tel Aviv University Ltd. (IL) 2003-12-17 EP disclosed
US-6632899-B2 Contains a diamine diphenolate complex and an activating co-catalyst RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2003-10-14 US disclosed
US-20020173604-A1 Active non-metallocene pre-catalyst and method for tactic catalytic polymerization of alpha-olefin monomers RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2002-11-21 US disclosed
WO-2002036638-A2 ACTIVE NON-METALLOCENE PRE-CATALYST AND METHOD FOR TACTIC CATALYTIC POLYMERIZATION OF ALPHA-OLEFIN MONOMERS RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220118379-A1 Separation of Radiometals SLC39A3, SLC30A6, SLC39A14 EGFR 271/4885ERBB2 2022/4885ALDH1A1 4561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.